PROGRAM
2021 IASL Annual Conference July 16-17, 2021
GMT+09:00 (Korea, Japan)
ROOM 1
JOINT 2
IASL & South America
Jul. 17 07:10-07:30
Long-Term Albumin Administration in Patients with Cirrhosis: How Good Is It?
Melissa Dirchwolff (Hospital Privado de Rosario, Argentina)
Jul. 17 07:30-07:50
Advances in Hepatic Encephalopathy
Manuela Merli (Sapienza University of Rome, Italy)
Jul. 17 07:50-08:10
Diagnosis and Impact of Sarcopenia in Patients with Cirrhosis
Juan Pablo Arab (Pontificia Universidad Catolica de Chile, Chile)
Jul. 17 08:10-08:30
Management of Bacterial Infections
Sebastian Marciano (Hospital Italiano de Buenos Aires, Argentina)
Jul. 17 08:30-08:50
Discussion
Session 9
Portal Hypertension in the 21st Century
Jul. 17 09:00-09:20
Where Are We Moving into Prevention and Treatment of Portal Hypertension?
Andres Cardenas (University of Barcelona, Spain)
Jul. 17 09:20-09:40
Recent Diagnostic Approah for Portal Hyertension
Moon Young Kim (Yonsei University Wonju, Korea)
Jul. 17 09:40-10:00
Variceal Bleeding - Update in Prevention and Treatment
Alexander Nersesov (Kazakh National Medical University, Kazakhstan)
Jul. 17 10:00-10:20
Is There a Global Perspective for Early and Elective TIPS-Implantation?
Virginia Hernandez-Gea (University of Barcelona, Spain)
Jul. 17 10:20-10:40
Discussion
Session 11
Complications of Cirrhosis
Jul. 17 10:50-11:10
Cirrhotic Cardiomyopathy: Comparing Old and New Definition Criteria
Marcel Razpotnik (Klinikum Klagenfurt am Wörthersee, Austria)
Jul. 17 11:10-11:30
Adverse Cardiovascular Events after Liver Transplantation
Manhal Izzy (Vanderbilt University Medical Center, USA)
Jul. 17 11:30-11:50
Update in Hepatopulmonary Syndrome and Portopulmonary Hypertension
Samir Gupta (University of Toronto, Canada)
Jul. 17 11:50-12:10
Advances in Hepatorenal Syndrome and Acute Kidney Injury
Florence Wong (University of Toronto, Canada)
Jul. 17 12:10-12:30
Discussion
Jul. 17 12:30-13:30
Lunch Break
Session 12
Management in Fatty Liver Disease
Jul. 17 13:30-13:50
Exercise to Improve Fatty Liver and Portal Hypertension
Takumi Kawaguchi (Kurume University, Japan)
Jul. 17 13:50-14:10
Nutritional Interventions for Fatty Liver Disease on the West
Shira Zelber-Sagi (University of Haifa, Israel)
Jul. 17 14:10-14:30
Awareness for Fatty Liver Disease - Are We Making Any Global Progress?
Faisal Sanai (King Saud University, Saudi Arabia)
Jul. 17 14:30-14:50
Pediatric Fatty Liver Disease and Risk of Adult Complications
Henning Grønbæk (Aarhus University, Denmark)
Jul. 17 14:50-15:10
Discussion
Presidential Lecture
Jul. 17 15:20-15:50
To Be Confirmed
Kwang-Hyub Han (NECA, Korea)
Session 13
Alcoholic Liver Disease in the 21 Century
Jul. 17 16:00-16:20
Alcoholic Hepatitis - How Can We Modify the Course?
Mark Thursz (Imperial College London, UK)
Jul. 17 16:20-16:40
Gut Microbiota and Alcoholic Liver Disease
Dong Joon Kim (Hallym University, Korea)
Jul. 17 16:40-17:00
Genetic Susceptibility to Alcoholic Liver Damage - Global Perspective
Felix Stickel (Hirslanden Private Hospital Group, Switzerland)
Jul. 17 17:00-17:20
Alcoholic Liver Damage - Best Practice for Public Health Improvement
Jürgen Rehm (University of Toronto, Canada)
Jul. 17 17:20-17:40
Discussion
Jul. 17 17:40-18:00
Wrap-Up & Closing
Markus Peck, President-Elect
ROOM 2
Session 10
Non-Invasive Assessment of Liver Fibrosis: A Case Based Approach
Jul. 17 09:00-09:20
Non-Alcoholic Fatty Liver Disease
Laurent Castera (University of Paris-VII, France)
Jul. 17 09:20-09:40
Chronic Hepatitis B
Seung Up Kim (Yonsei University, Korea)
Jul. 17 09:40-10:00
Cirrhosis
Massimo Pinzani (University College London, UK)
Jul. 17 10:00-10:20
Assessment of HCC Risk
Henry LY Chan (The Chinese University of Hong Kong, China)
Jul. 17 10:20-10:40
Discussion
JOINT 3
IASL & KLCA: HCC - Recent Advances in Prevention and Treatment
Jul. 17 13:00-13:15
The Changing Global Epidemiology and Prevention
Jidong Jia (Capital Medical University, China)
Jul. 17 13:15-13:30
AI-Prediction Model of HCC in Patients with Chronic Hepatitis B
Jeong-Hoon Lee (Seoul National University, Korea)
Jul. 17 13:30-13:45
Tenofovir vs. Entecavir for the Prevention of HCC
Sung Won Lee (The Catholic University of Korea, Korea)
Jul. 17 13:45-14:00
HCC Surveillance and Diagnosis in 2021
Mindie H. Nguyen (Stanford University, USA)
Jul. 17 14:00-14:15
Imaging Diagnosis of Macrotrabecular-Massive HCC
Hyungjin Rhee (Yonsei University, Korea)
Jul. 17 14:15-14:30
Application of AI in HCC Treatment
Gwang Hyeon Choi (Seoul National University, Korea)
Jul. 17 14:30-14:45
Pursuing Efficacious Combination Treatment for HCC
Ann-Lii Cheng (National Taiwan University, Taiwan)
Jul. 17 14:45-15:00
Sequential Treatment for Advanced HCC based on Real-World-Data
Masatoshi Kudo (Kindai University, Japan)
Jul. 17 15:00-15:20
Discussion